Glaxo Smith Kline (BIOC.CA) - Board of Directors' Meeting Decisions
Glaxo Smith Kline (BIOC.CA) Resume Trading
Company Name : Glaxo Smith Kline
ISIN Code : EGS38171C012
Reuters Code : BIOC.CA
Content :
EGX decided to resume trading on company's shares effective 04/03/2024 trading session at 11:45 AM, as the company sent the Board of Directors’ meeting decisions held on 03/03/2024.
The BoD Decisions (338 KB)
Release from the Company (251 KB)
Company Name : Glaxo Smith Kline
ISIN Code : EGS38171C012
Reuters Code : BIOC.CA
Content :
EGX decided to resume trading on company's shares effective 04/03/2024 trading session at 11:45 AM, as the company sent the Board of Directors’ meeting decisions held on 03/03/2024.
The BoD Decisions (338 KB)
Release from the Company (251 KB)
Comments